Toru Kondo

Professor

Hokkaido University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Tissue Engineering Tissue Engineering professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Toru Kondo is a faculty member at Hokkaido University in Japan. His research primarily focuses on novel therapeutic strategies for targeting cancer stem cells and glioblastoma-initiating cells, as well as understanding tumor cell heterogeneity and plasticity. Recent articles authored by Professor Kondo explore various approaches to tackle obesity-related metabolic disorders and retinal degeneration, underscoring his expertise in cancer biology and its therapeutic implications.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Noriaki Sasai

associate professor

Nara Institute of Science and Technology

JAPAN

View details

Ken-Ichiro Seino

Hokkaido University

JAPAN

View details

Shigeyuki Yokoyama

Head of RIKEN Yokoyama Laboratory

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Toru Kondo

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Novel strategy to target glioblastoma-initiating cells using a braintropic adeno-associated virus carrying a miR-dependent genome-editing system

Eva1 deficiency prevents obesity-induced metabolic disorders by reducing visceral adipose dysfunction

Combination of blockade of endothelin signalling and compensation of IGF1 expression protects the retina from degeneration

EVA1-antibody drug conjugate is a new therapeutic strategy for eliminating glioblastoma-initiating cells

Developing a novel therapeutic strategy against cancer stem cell heterogeneity and plasticity

Tumor cell-induced macrophage senescence plays a pivotal role in tumor initiation followed by stable growth in immunocompetent condition

Selective vulnerability of human-induced pluripotent stem cells to dihydroorotate dehydrogenase inhibition during mesenchymal stem/stromal cell purification

Glioblastoma-initiating cell heterogeneity generated by the cell-of-origin, genetic/epigenetic mutation and microenvironment

Cancer cell heterogeneity and plasticity: From molecular understanding to therapeutic targeting

Selective eradication of pluripotent stem cells by inhibiting DHODH activity

Collaborators (3)

Noriaki Sasai

Ken-Ichiro Seino

Shigeyuki Yokoyama

Make your next move.